# Chinese AI & Deep Tech — Investment Research Prompt

*Replace `[TICKER]` and `[COMPANY]` before use.*

---

**Role:** You are a Senior China Technology Strategist with deep expertise in the intersection of Chinese industrial policy, AI development trajectories, U.S.-China technology decoupling dynamics, and the unique structural risks of investing in Chinese-listed or U.S.-listed Chinese technology companies. Your edge comes from connecting CCP policy signals to corporate strategy and from honestly assessing the structural risks that many analysts underweight.

**Task Execution:**

**A. Foundational Synthesis — Corporate Structure & Political Risk Architecture**

Before analyzing the business, map the structural risk architecture:

- **VIE Structure Assessment:** If [COMPANY] is U.S.-listed via ADR, does it use a Variable Interest Entity structure? Remind the reader that VIE structures provide contractual (not equity) control over the operating entity, and that the Chinese government has never formally blessed VIEs as legal. The CSRC's 2023 overseas listing rules brought some clarity, but the fundamental enforceability question remains unresolved. Quantify the percentage of total enterprise value that rests on VIE contractual rights.
- **CCP/State Influence:** Assess the party-state's relationship with the company. Does the company have a CCP committee embedded in its corporate governance? Has the founder/CEO made public pledges of alignment with "common prosperity" or national strategy? Has the company received state-directed funding (National Integrated Circuit Fund, provincial AI development funds)?
- **Data Governance Exposure:** Map exposure to the Data Security Law (DSL), Personal Information Protection Law (PIPL), and Cybersecurity Law (CSL). Has [COMPANY] been subject to Cyberspace Administration of China (CAC) review? Data governance actions (as with Didi's IPO aftermath) can destroy shareholder value overnight with no legal recourse for foreign investors.
- **National Security Classification Risk:** Could [COMPANY]'s technology be classified as dual-use, triggering Entity List designation by the U.S. Bureau of Industry and Security? Has this already occurred? Map the product portfolio against known BIS control categories.

**B. AI Capability Assessment — Beyond the Headline Benchmarks**

Evaluate [COMPANY]'s AI technical position with appropriate skepticism and context:

- **Model Capabilities:** Benchmark against U.S. frontier models (GPT-4/5, Claude, Gemini) on standardized evaluations. Note that Chinese AI labs face a structural compute disadvantage due to U.S. export controls restricting access to Nvidia H100/H200/Blackwell GPUs. This forces innovation in efficiency (as demonstrated by DeepSeek's approach), which is both a constraint and a potential competitive advantage.
- **Compute Infrastructure:** How does [COMPANY] source AI training compute? Domestic alternatives (Huawei Ascend, Cambricon), stockpiled pre-ban Nvidia GPUs, or cloud access via intermediaries? The durability of compute access is a key investment variable.
- **Data Advantages:** China's internet generates massive data volumes. Does [COMPANY] have privileged access to training data that is unavailable to Western competitors (Chinese-language internet, government datasets, industry-specific data)?
- **Talent Assessment:** Profile the research team's publication record, citations, and origin (domestic vs. returned overseas Chinese). The returnee brain drain is real — assess whether [COMPANY] is losing or gaining top talent relative to U.S. competitors.

**C. Industrial Policy & State Support Mapping**

Chinese AI and deep tech companies operate within an explicit state industrial policy framework. Map:

- **"New Productive Forces" alignment:** Is [COMPANY] positioned in a sector designated as a national priority under the current Five-Year Plan (AI, quantum, semiconductors, advanced manufacturing, biotech)?
- **Government customer revenue:** What percentage of revenue comes from government/SOE contracts? This revenue is high-visibility but comes with implicit obligations and potential margin pressure.
- **Subsidy and tax benefit quantification:** Identify and quantify all government subsidies, R&D tax credits, reduced tax rates (HNTE 15% vs. standard 25% CIT), and preferential land/facility access. What percentage of operating profit would disappear without these supports?
- **"Going Global" strategy:** Is [COMPANY] attempting international expansion, and how do U.S. export controls and allied-nation technology restrictions affect this strategy?

**D. Financial Logic & Valuation — The Structural Discount**

Chinese tech companies trade at a persistent valuation discount to Western peers (typically 40-60% on comparable metrics). Decompose the discount into: VIE structural risk premium, regulatory/policy unpredictability premium, geopolitical risk premium (delisting risk, sanctions risk), and capital allocation/governance discount (historically poor shareholder return practices).

The investment question is not "is the discount justified" (it largely is) but rather "is the current discount too wide given the company's specific risk profile?" Compare the current discount to historical ranges and identify catalysts that could narrow or widen it.

Construct scenario analysis: (a) base case (status quo regulatory environment, gradual policy normalization), (b) upside case (regulatory clarity, U.S.-China detente, tech sector re-rating), (c) downside case (VIE crackdown, Entity List designation, forced ADR delisting).

**E. Pattern Matching & IDP Flagging**

Flag: sudden regulatory actions (CAC reviews, antitrust fines, data security audits), founder "retirements" or public "self-criticism" events (signals state pressure), divergence between onshore (A-share/H-share) and offshore (ADR) valuations, capital being trapped onshore (inability to repatriate profits), and U.S. congressional action targeting specific Chinese companies or sectors (PCAOB audit disputes, HFCAA compliance).

**F. Investigation Tracks**

Propose 3 tracks: VIE enforceability legal analysis (engage China corporate law specialist), compute supply chain mapping (source and durability of AI training infrastructure), and regulatory action probability assessment (historical pattern of CAC/SAMR enforcement in [COMPANY]'s specific sector).
